Sign inJoin waitlistJoin the waitlist

Bayard Powell

Section Chief, Cancer Medicine · Wake Forest University Baptist Medical Center

Credentials: · · · ·

History

Cancer Medicine Section · Wake Forest University Baptist Medical Center
Present
Cancer Medicine Section · Wake Forest University Baptist Medical Center
Present
Wake Forest University Baptist Medical Center
Present

Medical Oncology
1983–1985
Bowman Gray School of Medicine
1980–1983
University of North Carolina at Chapel Hill School of Medicine
1976–1980

Research

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
New England Journal of Medicine · 2006 · 2,720 citations
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B
Journal of Clinical Oncology · 2002 · 1,495 citations
Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B
New England Journal of Medicine · 1994 · 1,228 citations

JK
Jonathan Kolitz
89 papers
CB
Clara Bloomfield
82 papers
Richard Larson
76 papers
Richard Stone
68 papers
Guido Marcucci
48 papers · 1 as a fellow
Maria Baer
41 papers
JB
John Byrd
39 papers
MC
Michael Caligiuri
37 papers
Joseph Moore
29 papers
Wendy Stock
27 papers
Hyman Muss
26 papers
James Blachly
25 papers · 1 as a fellow

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $641.8K · Wake Forest University Health Sciences
1976–2022

Clinical trials

CPI-613 Given With Metformin in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Principal investigator · Withdrawn · Phase 2
Wake Forest University Health Sciences
2024–2025
CPI-613 and Hydroxychloroquine for Patients With High Risk Myelodysplastic Syndrome
Principal investigator · Withdrawn · Phase 1, Phase 2
Wake Forest University Health Sciences
2021–2027
Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Principal investigator · Completed · Phase 1
Wake Forest University Health Sciences
2016–2018
CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Principal investigator · Completed · Phase 1
Wake Forest University Health Sciences
2015–2022